Back to results
CompletedPhase 2

Long-Term Safety Extension With SR57667B in Patients With Alzheimer's Disease

NCT00285077

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Sanofi-Aventis Administrative Office

Laval, Canada

+6 additional locations

View on ClinicalTrials.gov
Long-Term Safety Extension With SR57667B in Patients With Alzheimer's Disease — TrialFind